IL1B and breast carcinoma: The NLRP3 inflammasome has been shown to promote breast cancer growth and metastasis by inducing IL-1β secretion, which stimulates angiogenesis, immune evasion, epithelial-mesenchymal transition (EMT), and stemness [63].